Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.111713
Revised: November 10, 2025
Accepted: December 22, 2025
Published online: April 19, 2026
Processing time: 202 Days and 1 Hours
Anxiety and depression adversely affect clinical outcomes in children with bron
To clarify the relationship between emotional state, treatment compliance, and symptom improvement in children with bronchopneumonia.
A total of 306 children with bronchopneumonia (January 2022 to January 2025) were included. Clinical data on emotional state (the Depression Self-Rating Scale for Children and the Screen for Child Anxiety Related Emotional Disorders), treatment compliance, and symptom improvement (time to wheezing, fever, lung rales, and cough resolution) were collected. Anxiety/depression status across different clinical characteristics was assessed, and its correlation with treatment compliance and symptom improvement was analyzed.
Depression Self-Rating Scale for Children and Screen for Child Anxiety Related Emotional Disorders scores were significantly higher in children with a disease duration > 4 days and moderate illness but showed no significant correlation with gender or age. Anxious or depressed children showed markedly lower overall compliance, with longer symptom-resolution times.
In pediatric bronchopneumonia, adverse emotional states are closely associated with poorer treatment compliance and slower symptom improvement. Reducing anxiety or depression may enhance compliance and alleviate sym
Core Tip: In 306 children with bronchopneumonia, emotional state was evaluated in relation to treatment compliance and symptom improvement. Anxiety/depression was strongly associated with lower compliance and slower symptom recovery, supporting targeted clinical psychological intervention to enhance children’s compliance and consequently accelerate rehabilitation. The findings of this study provide an important breakthrough for the rapid recovery of children with bron
